Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T G Beach

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Current Alzheimer Research|September 1, 2009
Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and ADM N Sabbagh, K Cooper, J DeLange, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Cortical cholinergic denervation elicits vascular A beta depositionA E Roher, Y M Kuo, P E Potter, et al.
European Journal of Neurology|November 1, 2015
Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohortsJ N Caviness, R L Utianski, J G Hentz, et al.
The American Journal of Pathology|March 7, 2000
Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolismY M Kuo, T A Kokjohn, M D Watson, et al.
The Journal of Biological Chemistry|January 22, 2001
Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brainsY M Kuo, T A Kokjohn, T G Beach, et al.
Neuroscience Letters|March 24, 2000
Cholinergic deafferentation of the rabbit cortex: a new animal model of Abeta depositionT G Beach, P E Potter, Y M Kuo, et al.
Molecular Medicine (Cambridge, Mass.)|January 10, 2002
The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer diseaseY M Kuo, T G Beach, L I Sue, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Dyrk1a inhibition with the Novel Compound DYR533: A Cross-Disease Therapeutic Strategy Targeting Amyloidosis, Tau Pathogenesis, and NeuroinflammationS K Bartholomew, J Turk, W Winslow, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Transcriptomic profiling of the middle temporal gyrus reveals differential glial/neuronal dysregulation across Alzheimer's disease and agingI S Piras, A Bonfitto, S Song, et al.
European Journal of Neurology|August 24, 2017
GBA mutations in Parkinson disease: earlier death but similar neuropathological featuresC H Adler, T G Beach, H A Shill, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Current Alzheimer Research|September 1, 2009
Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and ADM N Sabbagh, K Cooper, J DeLange, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Cortical cholinergic denervation elicits vascular A beta depositionA E Roher, Y M Kuo, P E Potter, et al.
European Journal of Neurology|November 1, 2015
Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohortsJ N Caviness, R L Utianski, J G Hentz, et al.
The American Journal of Pathology|March 7, 2000
Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolismY M Kuo, T A Kokjohn, M D Watson, et al.
The Journal of Biological Chemistry|January 22, 2001
Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brainsY M Kuo, T A Kokjohn, T G Beach, et al.
Neuroscience Letters|March 24, 2000
Cholinergic deafferentation of the rabbit cortex: a new animal model of Abeta depositionT G Beach, P E Potter, Y M Kuo, et al.
Molecular Medicine (Cambridge, Mass.)|January 10, 2002
The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer diseaseY M Kuo, T G Beach, L I Sue, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Dyrk1a inhibition with the Novel Compound DYR533: A Cross-Disease Therapeutic Strategy Targeting Amyloidosis, Tau Pathogenesis, and NeuroinflammationS K Bartholomew, J Turk, W Winslow, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Transcriptomic profiling of the middle temporal gyrus reveals differential glial/neuronal dysregulation across Alzheimer's disease and agingI S Piras, A Bonfitto, S Song, et al.
European Journal of Neurology|August 24, 2017
GBA mutations in Parkinson disease: earlier death but similar neuropathological featuresC H Adler, T G Beach, H A Shill, et al.
Pageof 6